Clinical Trial Update: Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating NGX-4010 with open-label lidocaine/prilocaine cream for postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• NGX-4010 (capsaicin patch 8%)
• lidocaine 2.5% / prilocaine 2.5% cream (lidocaine/prilocaine cream)

Snippet

Sponsor: NeurogesX | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED